| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | pazopanib | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 2 | Clozapine | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | Sorafenib | FAERS: 2 | US FAERS | |
| 4 | 5-[[4-[2-(5-Ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydron;chloride | FAERS: 1 | US FAERS | |
| 5 | Exenatide | FAERS: 1 | US FAERS | |
| 6 | Teriparatide | FAERS: 1 | US FAERS | |
| 7 | Valsartan | FAERS: 1 | US FAERS | |
| 8 | Zoledronic Acid | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120267
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.